By following this link you'll go directly to the site map at the end of each page
IT (EN)
   Person in charge: Alberto Mantovani
You're in:
 Recently updated

Adverse outcome pathways: opportunities, limitations and open questions

"Adverse outcome pathways: opportunities, limitations and open questions" Arch Toxicol. 2017 Oct 19. doi: 10.1007/s00204-017-2045-3. [Epub ahead of print]
elaborated within the H2020 Project Eu-ToxRisk.

Marcel Leist, Ahmed Ghallab, Rabea Graepel, Rosemarie Marchan, Reham Hassan, Susanne Hougaard Bennekou, Alice Limonciel, Mathieu Vinken, Stefan Schildknecht, Tanja Waldmann, Erik Danen, Ben van Ravenzwaay, Hennicke Kamp, Iain Gardner, Patricio Godoy, Frederic Y. Bois, Albert Braeuning, Raymond Reif, Franz Oesch, Dirk Drasdo, Stefan Höhme, Michael Schwarz, Thomas Hartung, Thomas Braunbeck, Joost Beltman, Harry Vrieling, Ferran Sanz, Anna Forsby, Domenico...

Published 10-24-2017 in Emerging aspects , last update 10-24-2017 More...

Share: 

Food Chains and Ecosystems

This section collects scientific references on possible approaches aimed to mitigate the exposure and/or hazard from endocrine disrupters and other contaminants in food chains and the environment .

5documents

Italian Research - Toxicological risk assessment: effects and exposure

Literature from 2001 to current year

The bibliographic citation section pertaining to Italian Research in Toxicological risk assessment field: effects and exposure.

Published 03-01-2010 in Italian research , last update 06-12-2017 More...

Share: 

Expert survey on identification of gaps in available test methods for evaluation of endocrine disruptors

Expert survey on identification of gaps in available test methods for evaluation of endocrine disruptors

According to the 2012 WHO/UNEP publication 'State of the Science of Endocrine Disrupting Chemicals' research into endocrine disrupting chemicals over the last decade has indicated that, despite the progress achieved in development and validation of test methods for evaluation of endocrine disruptors, there are still several gaps that need to be addressed. Considering the expected significant amount of work needed to fill the gaps and the limited resources available, it will be important to set priorities for the upcoming period (next 5-10 years) for the development and validation of test methods. Thus there is a need to focus the European input to the OECD test...

Published 05-30-2017 in Emerging aspects , last update 05-30-2017 More...

Share: 

Legal information


© - Istituto Superiore di Sanità Viale Regina Elena 299 - 00161 - Roma (I)
Partita I.V.A. 03657731000 - C.F. 80211730587 - Legal information

ISS Home

Informiamo i visitatori, in virtù della individuazione delle modalità semplificate per l'informativa e l'acquisizione del consenso per l'uso dei cookie - 8 maggio 2014 (Pubblicato sulla Gazzetta Ufficiale n. 126 del 3 giugno 2014), che questo sito utilizza direttamente solo cookie tecnici.[Ho letto]